Authors: Spinelli FR, Conti F, Gadina M
PMID: 32385052 DOI: 10.1126/sciimmunol.abc5367
Abstract
JAK kinase inhibitors are being investigated as a way of managing cytokine storm in severe COVID-19 patients.
Keywords: SARS-CoV-2, JAK inhibitors, COVID-19
Source: https://pubmed.ncbi.nlm.nih.gov/32385052/
Archive: https://archive.ph/Jwcrd